What information is required for a Vyvanse (lisdexamfetamine) refill?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To refill Vyvanse, you will need to provide your full name, date of birth, contact information, prescription number, prescribing doctor's name, pharmacy details, and insurance information, and due to its status as a Schedule II controlled substance, a new prescription is typically required for each refill, which may involve a doctor's appointment to assess treatment progress. When requesting a refill, it's essential to consider the regulations surrounding controlled substances, such as Vyvanse, which is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and binge eating disorder 1.

Given the potential risks associated with Vyvanse, especially in certain populations like pregnant or breastfeeding women, as noted in studies on attention-deficit/hyperactivity disorder in pregnancy and the postpartum period 1, it's crucial to closely monitor its use. The study highlights that there is limited published information on the use of lisdexamfetamine in pregnancy and while breastfeeding, emphasizing the need for careful consideration and monitoring in these cases.

Key information needed for a refill includes:

  • Full name
  • Date of birth
  • Contact information
  • Prescription number
  • Prescribing doctor's name
  • Pharmacy details
  • Insurance information

It's also important to plan ahead for refills, as pharmacies must verify controlled substance prescriptions, a process that can take time. Contacting your healthcare provider 5-7 days before running out of medication can help ensure continuous treatment and prevent potential withdrawal symptoms or the return of underlying symptoms.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Indicated PopulationInitial DoseTitration ScheduleRecommended DoseMaximum Dose ADHD (Adults and pediatric patients 6 years and older) (2.2)30 mg every morning10 mg or 20 mg weekly30 mg to 70 mg per day70 mg per day BED (Adults) (2.3)30 mg every morning20 mg weekly50 mg to 70 mg per day70 mg per day Prior to treatment, assess for presence of cardiac disease. (2. 4) Severe renal impairment: Maximum dose is 50 mg/day. (2.5) End stage renal disease (ESRD): Maximum dose is 30 mg/day. (2.5)

To refill Vyvanse (lisdexamfetamine), the following information is required:

  • Patient's identity and medical history
  • Current dose and titration schedule
  • Indication for use (ADHD or BED)
  • Presence of cardiac disease or other serious medical conditions
  • Renal function (for patients with severe renal impairment or ESRD) The prescriber should also monitor for signs of abuse, misuse, and addiction 2.

From the Research

Required Information for a Vyvanse Refill

To refill a Vyvanse (lisdexamfetamine) prescription, the following information is typically required:

  • Patient's name and date of birth
  • Prescription number and expiration date
  • Name and contact information of the prescribing doctor
  • Dosage and frequency of the medication
  • Number of refills remaining

Additional Information

The pharmacy may also require additional information, such as:

  • Patient's medical history and current medications
  • Insurance information and payment details
  • Any changes to the patient's condition or treatment plan

Studies on Lisdexamfetamine

According to studies 3, 4, 5, 6, 7, lisdexamfetamine is a prodrug that is hydrolyzed to its active form, d-amphetamine, in the body. It is used to treat attention-deficit/hyperactivity disorder (ADHD) and has a lower abuse potential compared to other stimulants.

Key Points

  • Lisdexamfetamine is a therapeutically inactive molecule that is converted to d-amphetamine in the body 6
  • The pharmacokinetics of lisdexamfetamine suggest a reduced potential for abuse 6, 7
  • Lisdexamfetamine has been shown to be effective in improving symptoms of ADHD in children and adults 3, 4
  • The medication should be used under the guidance of a healthcare professional and with careful monitoring of the patient's condition and treatment plan 3, 4, 5, 6, 7

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.